Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis
暂无分享,去创建一个
K. Muro | I. Oze | Y. Niwa | M. Ishihara | Tsutomu Tanaka | M. Tajika | M. Muto | T. Abe | T. Ura | H. Taniguchi | M. Nomura | R. Kawai | S. Kadowaki | N. Uemura | T. Masuishi | Y. Narita | A. Komori | M. Andoh